Evotec SE
Latest round
- Series A
Last raised
- Apr 2004
Total raised
- $31M
Investors
- 5
About Evotec SE
Evotec SE is a biotechnology company founded in 1993 and headquartered in Hamburg, Germany. The company specializes in drug discovery and development services, adapting its business strategies to meet evolving market demands. Rudolf Rigler, a pivotal figure in its establishment, led the company through various phases of growth. In May 2025, Evotec SE agreed to acquire Fortaco Gruza from Fortaco Group Oy. Evotec is a biotechnology company that specializes in research and development (R&D) services aimed at addressing unmet medical needs across various therapeutic areas. Its core offerings include high-value pipeline co-creation partnerships and comprehensive Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services. These services accelerate drug development processes from initial disease understanding through to Investigational New Drug (IND) submission and Phase 1 clinical trials. Evotec's expertise extends particularly to small molecules and biotherapeutics, leveraging advanced technologies such as artificial intelligence and continuous manufacturing to enhance the quality and accessibility of high-quality therapeutics. The company collaborates with a diverse range of clients, including pharmaceutical and biotechnology firms, primarily operating in markets across Europe, North America, and parts of Asia, seeking innovative solutions to advance their drug discovery and development efforts.
Who invested in Evotec SE
5 investors across 1 round
See all investors in Evotec SE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 2, 2004
Amount
$31M
Investors
Questions about Evotec SE
Who invested in Evotec SE?
Evotec SE has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evotec SE raised?
Evotec SE has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evotec SE last raise money?
Evotec SE's most recent round on record is a Series A, in Apr 2004.
What does Evotec SE do?
Evotec SE is a biotechnology company founded in 1993 and headquartered in Hamburg, Germany.
Where is Evotec SE headquartered?
Evotec SE is headquartered in Hamburg, Germany.
Which VCs invest in companies like Evotec SE?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Evotec SE's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Evotec SE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.